VIEW NOW Reducing GI impact of NSAIDs: a multidisciplinary perspective
By Dr Sue Lipscombe, Professor Peter Hayes and Dr Karen Simpson, 07 October 2010
Learn more about the challenges presented by NSAID therapy and how these can be minimised.
Learn more about the challenges presented by NSAID therapy and how these can be minimised.
Further Reading
- Related MIMS Guidelines and Summaries
- WHO Pain Ladder for Cancer Pain Relief
- Back Pain (Low), Acute and Chronic
- Acupuncture
Send to a friend
Latest Stories from GP
- GP's e-petition to scrap Health Bill 'best supported yet'
- Bowel disorder deaths halved in three years by NHS care
- Screen for inherited heart disease risk, charity urges
- GPs dispute Audit Commission claims list cleaning ghost patients saves £6m
- Practice-run lifestyle sessions for teenagers 'cut obesity'
Additional Information
Latest jobs Jobs web feed
- 2X Part Time Salaried GPs Deerness Park Medical Centre Competitive, Sunderland Tyne & Wear
- Locum GPs Urgently South East and South West London- Earn up to £70 per hour! Merco Up to £70/hour, South East and South West London
- General Family Medicine Practitioner Job - New Zealand International Medical Recruitment NZD $120,000 - $160,000, North Island, New Zealand
- General Family Medicine Practitioner Job - New Zealand International Medical Recruitment NZD $140,000 - $180,000, North Island, New Zealand
- General Family Medicine Practitioner Job - Australia International Medical Recruitment AUD $200,000 - $300,000, New South Wales, Australia
- Salaried GP positions in South London HCL International £68K to £80K per annum, South London
Most read
- DH blamed as UK-wide shingles jab is delayed
- RCGP backs care excellence standard for lesbian, gay and bisexual patients
- GPC writes to health secretary calling for NHS 111 roll-out slow-down
- New blood thinning agent approved for GPs in Scotland
- Downing Street Health Bill summit angers BMA
- #weekinreview - 17 February
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
